MIMEDX Announces First Quarter 2022 Operating and Financial

First Quarter Net Sales of $58.9 Million Reflects Double-Digit Revenue Increase for the Third Straight Quarter in the Company's Continuing Portfolio of...

Related Keywords

United States , Japan , Robert Stein , Timothyr Wright , Rohit Kashyap , Product Development , Us Food Drug Administration , Company Continuing Portfolio Of Products , Mimedx Group Inc , Company Tissue Other , Nasdaq , First Quarter Net Sales , Reflects Double Digit Revenue Increase , Third Straight Quarter , Continuing Portfolio , Host Conference Call , Medx Group , Executive Officer , Advanced Wound Care , Surgical Recovery , Placental Collagen Matrix , Human Amnion Chorion Membrane , Knee Osteoarthritis , Wound Care , Regenerative Medicine , Biologics Innovation , Drug Administration , Financial Highlights , Spring Meeting , Costs While Preserving Lives , Medicare Patients , Lower Extremity Diabetic Ulcers , Placental Biologics Retain Critical Activity , Healing Fibrotic Wounds , First Quarter , Months Ended March , Unaudited Financial , Nasdaq Mdxg , Mimedx Group , Nc ,